Sign in

CIK 0001437402

  • Large accelerated filer

ARDELYX, INC.

Sign in to watch
Ticker
ARDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-745-7047
Business address
34175 ARDENWOOD BLVD., FREMONT, CA, 94555
Former names
NTERYX INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-04-27 GRAMMER ELIZABETH A Sale −1,446 $7.54 $11K 117,986
2020-04-27 GRAMMER ELIZABETH A Sale −2,500 $7.52 $19K 115,486
2020-04-27 GRAMMER ELIZABETH A Sale −3,542 $7.49 $27K 111,944
2020-04-27 GRAMMER ELIZABETH A Sale −10,336 $7.44 $77K 101,608
2020-04-17 RAAB MICHAEL President & CEO Sale −9,428 $7.02 $66K 89,812
2020-04-16 RAAB MICHAEL President & CEO Sale −10,500 $7.01 $74K 99,240
2020-04-15 RAAB MICHAEL President & CEO Sale −500 $7.03 $4K 109,740
2020-03-12 Cadoret-Manier Onaiza Director Grant or award · Stock Option (Right to Buy) +65,890 65,890
2020-03-02 RAAB MICHAEL President & CEO Exercise or conversion +11,123 $1.08 $12K 219,180
2020-03-02 RAAB MICHAEL President & CEO Sale −11,123 $7.00 $78K 208,057
2020-03-02 RAAB MICHAEL President & CEO Sale −20,428 $7.01 $143K 110,240
2020-03-02 RAAB MICHAEL President & CEO Exercise or conversion · Stock Option (Right to Buy) −11,123 0
2020-02-05 RAAB MICHAEL President & CEO Exercise or conversion +25,000 $1.08 $27K 231,828
2020-02-05 RAAB MICHAEL President & CEO Sale −25,000 $7.32 $183K 206,828
2020-02-05 RAAB MICHAEL President & CEO Exercise or conversion · Stock Option (Right to Buy) −25,000 11,123
2020-01-21 Rosenbaum David P. Chief Development Officer Grant or award · Stock Option (Right to Buy) +47,500 47,500

Page 38 of 38 · 756 trades